CheckMyRecalls

Important Safety Information on CRYSVITA (burosumab) and the… recall

Important Safety Information on CRYSVITA (burosumab) and the Risk of Severe Hypercalcemia in Patients with Tertiary Hyperparathyroidism

Published
25 Aug 2025
Agency
Health Canada
Country
Canada

The hazard

New safety information - Product safety

What to do

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official Health Canada notice

Source: Health Canada, published 25 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.